-
New therapeutic agent entering Phase 1 trials that has been reported to block a protein (common in many cancers) responsible for tumour growth. Best to wait for results before assigning the “holy grail” designation noted in some reports.
Medical Mythbusting Commentary for August 8, 2023 Source:Cancer-killing pill that annihilates tumours hailed as ‘holy grail’ breakthroughReference: Small molecule targeting of transcription-replication conflict for selective chemotherapy